The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV
Abstract
Approximately 80 percent of all human sera that react with antigens of HTLV-III, the etiologic agent of the acquired immune deficiency syndrome (AIDS), recognize protein bands at 66 and 51 kilodaltons. A mouse hybridoma was produced that was specific to these proteins. Repeated cloning of the hybridoma did not separate the two reactivities. The p66/p51 was purified from HTLV-III lysates by immunoaffinity chromatography and subjected to NH2-terminal Edman degradation. Single amino acid residues were obtained in 17 successive degradation cycles. The sequence determined was a perfect translation of the nucleotide sequence of a portion of the HTLV-III pol gene. The purified p66/51 had reverse transcriptase activity and the monoclonal immunoglobulin G specifically removed the enzyme activity from crude viral extract as well as purified enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Popovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200935 · Cited by 3,535
Self-citationComplete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
Self-citationA gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., & Broder, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7096 · Cited by 1,866
Self-citationSarngadharan, M. G., Popovic, M., Bruch, L., Schüpbach, J., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6324345 · Cited by 1,148
Self-citationMajor Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-III
Allan, J. S., Coligan, J. E., Barin, F., McLane, M. F., Sodroski, J. G., Rosen, C. A., Haseltine, W. A., Lee, T. H., & Essex, M. (1985) · Science · doi:10.1126/science.2986290 · Cited by 572
Characterization of gp41 as the Transmembrane Protein Coded by the HTLV-III/LAV Envelope Gene
Veronese, F. D., DeVico, A. L., Copeland, T. D., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1985) · Science · doi:10.1126/science.2994223 · Cited by 437
Self-citationSuramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-III
Mitsuya, H., Popovic, M., Yarchoan, R., Matsushita, S., Gallo, R. C., & Broder, S. (1984) · Science · doi:10.1126/science.6091268 · Cited by 397
Self-citationRobey, W. G., Safai, B., Oroszlan, S., Arthur, L. O., Gonda, M. A., Gallo, R. C., & Fischinger, P. J. (1985) · Science · doi:10.1126/science.2984774 · Cited by 349
Self-citationTheory and methods for immunization in culture and monoclonal antibody production
Reading, C. L. (1982) · Journal of Immunological Methods · doi:10.1016/0022-1759(82)90175-2 · Cited by 210
Cited by
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Huang, H., Chopra, R., Verdine, G. L., & Harrison, S. C. (1998) · Science · doi:10.1126/science.282.5394.1669 · Cited by 1,420
Molecular Targets for AIDS Therapy
Mitsuya, H., Yarchoan, R., & Broder, S. (1990) · Science · doi:10.1126/science.1699273 · Cited by 732
A structural model for the retroviral proteases
Pearl, L. H., & Taylor, W. R. (1987) · Nature · doi:10.1038/329351a0 · Cited by 598
Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase
Davies, J. F., Hostomska, Z., Hostomsky, Z., Jordan, S. R., & Matthews, D. A. (1991) · Science · doi:10.1126/science.1707186 · Cited by 570
Sarafianos, S. G., Marchand, B., Das, K., Himmel, D. M., Parniak, M. A., Hughes, S. H., & Arnold, E. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.071 · Cited by 535
Mechanism and fidelity of HIV reverse transcriptase.
Kati, W. M., Johnson, K. A., Jerva, L. F., & Anderson, K. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35706-5 · Cited by 492
Strategies for antiviral therapy in AIDS
Mitsuya, H., & Broder, S. (1987) · Nature · doi:10.1038/325773a0 · Cited by 487
RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase.
Tuerk, C., MacDougal, S., & Gold, L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6988 · Cited by 415
Shirasaka, T., Kavlick, M. F., Ueno, T., Gao, W. Y., Kojima, E., Alcaide, M. L., Chokekijchai, S., Roy, B. M., Arnold, E., & Yarchoan, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2398 · Cited by 386
Peng, C., Ho, B. K., Chang, T. W., & Chang, N. T. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2550-2556.1989 · Cited by 371
Pettit, S. C., Moody, M. D., Wehbie, R. S., Kaplan, A. H., Nantermet, P. V., Klein, C. A., & Swanstrom, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8017-8027.1994 · Cited by 355
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.
Lange, J. M., Paul, D. A., Huisman, H. G., de Wolf, F., van den Berg, H., Coutinho, R. A., Danner, S. A., van der Noordaa, J., & Goudsmit, J. (1986) · BMJ · doi:10.1136/bmj.293.6560.1459 · Cited by 340
Layne, S. P., Merges, M. J., Dembo, M., Spouge, J. L., Conley, S. R., Moore, J. P., Raina, J. L., Renz, H., Gelderblom, H. R., & Narat, P. L. (1992) · Virology · doi:10.1016/0042-6822(92)90593-e · Cited by 332
Le GRICE, S. F. J., & GRÜNINGER‐LEITCH, F. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15306.x · Cited by 329
Bebenek, K., Abbotts, J., Roberts, J. D., Wilson, S. H., & Kunkel, T. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84799-3 · Cited by 310
Lightfoote, M. M., Coligan, J. E., Folks, T. M., Fauci, A. S., Martin, M. A., & Venkatesan, S. (1986) · Journal of Virology · doi:10.1128/jvi.60.2.771-775.1986 · Cited by 310
Mervis, R. J., Ahmad, N., Lillehoj, E. P., Raum, M. G., Salazar, F. H., Chan, H. W., & Venkatesan, S. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.3993-4002.1988 · Cited by 310
Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS)
Kaplan, M. H., Sadick, N., Scott McNutt, N., Meltzer, M., Sarngadharan, M. G., & Pahwa, S. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70066-8 · Cited by 301
Self-citationHo, D. D., Sarngadharan, M. G., Hirsch, M. S., Schooley, R. T., Rota, T. R., Kennedy, R. C., Chanh, T. C., & Sato, V. L. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.2024-2028.1987 · Cited by 294
Self-citationNew Human T-Lymphotropic Retrovirus Related to Simian T-Lymphotropic Virus Type III (STLV-III AGM )
Kanki, P. J., Barin, F., M'Boup, S., Allan, J. S., Romet-Lemonne, J. L., Marlink, R., McLane, M. F., Lee, T.-H., Arbeille, B., Denis, F., et al. (1986) · Science · doi:10.1126/science.3006256 · Cited by 293
Perno, C. F., Yarchoan, R., Cooney, D. A., Hartman, N. R., Webb, D. S., Hao, Z., Mitsuya, H., Johns, D. G., & Broder, S. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.933 · Cited by 285
Miller, C. J., Alexander, N. J., Sutjipto, S., Lackner, A. A., Gettie, A., Hendrickx, A. G., Lowenstine, L. J., Jennings, M., & Marx, P. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4277-4284.1989 · Cited by 283
Debouck, C., Gorniak, J. G., Strickler, J. E., Meek, T. D., Metcalf, B. W., & Rosenberg, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.8903 · Cited by 278
HIV-1 Reverse Transcriptase Is a Target for Cytotoxic T Lymphocytes in Infected Individuals
Walker, B. D., Flexner, C., Paradis, T. J., Fuller, T. C., Hirsch, M. S., Schooley, R. T., & Moss, B. (1988) · Science · doi:10.1126/science.2451288 · Cited by 267
Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24
Veronese, F. D., Copeland, T. D., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1988) · Journal of Virology · doi:10.1128/jvi.62.3.795-801.1988 · Cited by 203
Self-citationIdentification and characterization of HIV-specific RNase H by monoclonal antibody
Hansen, J., Schulze, T., Mellert, W., & Moelling, K. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02805.x · Cited by 190
Furfine, E. S., & Reardon, J. E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52449-2 · Cited by 181
Gopalakrishnan, V, Peliska, J. A., & Benkovic, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10763 · Cited by 175
Park, J., & Morrow, C. D. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.5111-5117.1991 · Cited by 163
RNase H activity: structure, specificity, and function in reverse transcription
Schultz, S. J., & Champoux, J. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.007 · Cited by 150
DeStefano, J. J., Buiser, R. G., Mallaber, L. M., Myers, T. W., Bambara, R. A., & Fay, P. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89464-2 · Cited by 146
Huber, H. E., & Richardson, C. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86984-8 · Cited by 127
Chung, S., Himmel, D. M., Jiang, J.-K., Wojtak, K., Bauman, J. D., Rausch, J. W., Wilson, J. A., Beutler, J. A., Thomas, C. J., Arnold, E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000757 · Cited by 80
Le Grice, S. F. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.389056 · Cited by 73
RNase H activity of HIV reverse transcriptases is confined exclusively to the dimeric forms
Restle, T., Müller, B., & Goody, R. S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80172-d · Cited by 68
DeStefano, J. J., Mallaber, L. M., Fay, P. J., & Bambara, R. A. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.18.3793 · Cited by 60
Singh, A. K., & Das, K. (2022) · Viruses · doi:10.3390/v14051027 · Cited by 58
Keck, J. L., & Marqusee, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2740 · Cited by 52
Schultz, S. J., Zhang, M., & Champoux, J. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510504200 · Cited by 35
Past, Present, and Future Drug Delivery Systems for Antiretrovirals
Kirtane, A. R., Langer, R., & Traverso, G. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.09.015 · Cited by 28
Insight into the mechanism of a peptide inhibitor of HIV reverse transcriptase dimerization
Depollier, J., Hourdou, M.-L., Aldrian-Herrada, G., Rothwell, P., Restle, T., & Divita, G. (2005) · Biochemistry · doi:10.1021/bi0484264 · Cited by 28
Physical mapping of HIV reverse transcriptase to the 5′ end of RNA primers
DeStefano, J. J., Cristofaro, J. V., Derebail, S., Bohlayer, W. P., & Fitzgerald-Heath, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103958200 · Cited by 25
Metadata
- Authors
- di Marzo Veronese, F., Copeland, T. D., DeVico, A. L., Rahman, R., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G.
- Venue
- Science
- Published
- 1986-03-14
- Volume
- 231
- Issue
- 4743
- Pages
- 1289-1291
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2011153626
- Cited by
- 545
- References
- 15
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.